Exparel in Minimally Invasive Cardiac Surgery

PHASE4TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cardiac Disease
Interventions
DRUG

Exparel infiltration

Exparel infiltrated into wound and chest tube sites

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER

NCT02008370 - Exparel in Minimally Invasive Cardiac Surgery | Biotech Hunter | Biotech Hunter